RAPID UTI
Financiado
AN IMMUNOASSAY-BASED POINT OF CARE TEST KIT FOR RAPID, INEXPENSIVE AND EFFORTLES...
AN IMMUNOASSAY-BASED POINT OF CARE TEST KIT FOR RAPID, INEXPENSIVE AND EFFORTLESS DETECTION OF URINARY TRACT INFECTIONS
Urinary Tract Infection (UTI) is the most common infectious disease seen in humans. Also, UTI ranks as the Number 1 infection that leads to a prescription of antibiotics. Just in 2019, 404,6 million different UTI cases emerged wo...
Urinary Tract Infection (UTI) is the most common infectious disease seen in humans. Also, UTI ranks as the Number 1 infection that leads to a prescription of antibiotics. Just in 2019, 404,6 million different UTI cases emerged worldwide that costed tens of billions of euros to economies and caused around 236.000 deaths. Luckily, UTIs can be cured effectively with right treatment. The problems need to be resolved are: diagnosing of UTI takes a long time (2-7 days), requires expertise and is costly; high false positive rates and contamination risk causes unnecessary laboratory costs and workload; empirical treatment given without waiting for long culture results leads to unnecessary and/or wrong antibiotic usage and consequently to antibiotic resistance.
As Nanomed Diagnostic, we developed an immunoassay-based point of care test kit for rapid, inexpensive and effortless detection of UTIs (RAPID UTI). It can diagnose UTI just in 5 minutes. It provides at least 10 times less cost for diagnosis by eliminating several technical processes and costly equipment and consumable investments. It eliminates all unnecessary laboratory costs and workload caused by false-positives and contaminated samples. It prevents unnecessary or wrong antibiotic usage and the bacteria to develop resistance to antibiotics.
Within the scope of the 12-month planned project, meetings will be held with European potential customers and distributors, samples will be sent, improvements will be made according to the feedback received, certification studies will be completed, product promotion will be made by participating in fairs, exhibitions and conferences, printed and digital marketing materials will be prepared, and a clinical trial will be conducted in an EU origin institution.
ver más
Duración del proyecto: 12 meses
Fecha Inicio: 2023-06-07
Fecha Fin: 2024-06-30
Fecha Fin: 2024-06-30
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-06-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
HORIZON-EIE-2022-SCALEUP-02-02:
Women TechEU
Cerrada
hace 2 años
Presupuesto
El presupuesto total del proyecto asciende a
75K€
Líder del proyecto
NANOMED DIAGNOSTIC BIYOTEKNOLOJI ARGE LIMITED...
No se ha especificado una descripción o un objeto social para esta compañía.
